General Information of Drug (ID: DMNZG8T)

Drug Name
PF-821385 Drug Info
Synonyms PF-348089; Gp120 inhibitor (HIV), Pfizer
Indication
Disease Entry ICD 11 Status REF
Human immunodeficiency virus infection 1C62 Preclinical [1]
Cross-matching ID
TTD Drug ID
DMNZG8T

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fostemsavir DM50ILT Human immunodeficiency virus infection 1C62 Approved [3]
AIDSVAX DMS2WV3 Human immunodeficiency virus infection 1C62 Phase 3 [4]
Multi-envelope HIV vaccine DMAGCHE Human immunodeficiency virus infection 1C62 Phase 1 [5]
BMS-488043 DMRPU10 Human immunodeficiency virus infection 1C62 Discontinued in Phase 2 [6]
Pro 542 DMLOGR3 Human immunodeficiency virus infection 1C62 Discontinued in Phase 2 [7]
CD4 red blood cell electroinsertion DMIV82T Discovery agent N.A. Investigative [8]
⏷ Show the Full List of 6 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Human immunodeficiency virus Envelope glycoprotein gp120 (HIV gp120) TTBYP1X ENV_HV1H2 Inhibitor [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023943)
2 Increased Functional Stability and Homogeneity of Viral Envelope Spikes through Directed Evolution. PLoS Pathog. 2013 February; 9(2): e1003184.
3 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2020
4 HIV gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen. Drugs R D. 2003;4(4):249-53.
5 An assessment of the role of chimpanzees in AIDS vaccine research. Altern Lab Anim. 2008 Sep;36(4):381-428.
6 The investigations on HIV-1 gp120 bound with BMS-488043 by using docking and molecular dynamics simulations.J Mol Model.2013 Feb;19(2):905-17.
7 Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542. Antimicrob Agents Chemother. 2004 Feb;48(2):423-9.
8 Red blood cells bearing CD4 bind to gp120 covered plates and aggregate with cells expressing gp120. J Acquir Immune Defic Syndr. 1990;3(11):1041-5.